✦ LIBER ✦

Diagnosis and treatment of acquired von Willebrand syndrome

✍ Scribed by Tiede, Andreas

Book ID: 120298599
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 568 KB
Volume: 130
Category: Article
ISSN: 0049-3848
DOI: 10.1016/S0049-3848(13)70003-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progress in the diagnosis and treatment

Progress in the diagnosis and treatment of acquired Von Willebrand's syndrome (AVWS) : A.B. Federici and P.M. Mannucci. A. Blanchi Bonomi Hemophilia and Thrombosis Center University of Milano, Via Pace 9, 20122 Milano, Italy

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Acquired von Willebrand syndrome

✍ M. T. ALVAREZ; V. JIMENEZ-YUSTE; J. GRACIA; M. QUINTANA; F. HERNANDEZ-NAVARRO 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB

Paediatric acquired von Willebrand Syndr

Paediatric acquired von Willebrand Syndrome

✍ A. WILL 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB

ACQUIRED VON WILLEBRAND'S SYNDROME

✍ L. Holland; A. Adamson; G. I. C. Ingram; D. G. Chalmers 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

Acquired von Willebrand syndrome: An upd

Acquired von Willebrand syndrome: An update

✍ Massimo Franchini; Giuseppe Lippi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

## Abstract Acquired von Willebrand syndrome (aVWS) is a rare bleeding disorder with laboratory findings similar to those for congenital von Willebrand disease (VWD). However, unlike congenital VWD, it arises in individuals with no personal or family history of bleeding. aVWS occurs in association

Acquired von Willebrand syndrome: Featur

Acquired von Willebrand syndrome: Features and management

✍ Hiroshi Mohri 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

Acquired von Willebrand syndrome (AvWS) is not a well-known bleeding disorder among clinicians and is associated with various underlying diseases. The clinical manifestations are similar to congenital von Willebrand disease. Diagnosis is confirmed mainly by a decrease of ristocetin cofactor activity